AU5096893A - Use of 4-hydrazono-1,4-dihydro-pyridine and/or 4-hydrazino-pyridine derivatives for treatment of hypertension and congestive heart failure - Google Patents

Use of 4-hydrazono-1,4-dihydro-pyridine and/or 4-hydrazino-pyridine derivatives for treatment of hypertension and congestive heart failure

Info

Publication number
AU5096893A
AU5096893A AU50968/93A AU5096893A AU5096893A AU 5096893 A AU5096893 A AU 5096893A AU 50968/93 A AU50968/93 A AU 50968/93A AU 5096893 A AU5096893 A AU 5096893A AU 5096893 A AU5096893 A AU 5096893A
Authority
AU
Australia
Prior art keywords
pyridine
hydrazono
hydrazino
hypertension
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50968/93A
Other languages
English (en)
Inventor
Michael John Bohanon
Yoshiji Fujita
Michael S Lajiness
Paul Kosta Tomich
Kazuo Tsuzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU5096893A publication Critical patent/AU5096893A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50968/93A 1992-10-06 1993-09-03 Use of 4-hydrazono-1,4-dihydro-pyridine and/or 4-hydrazino-pyridine derivatives for treatment of hypertension and congestive heart failure Abandoned AU5096893A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95805392A 1992-10-06 1992-10-06
US958053 1992-10-06
PCT/US1993/008156 WO1994007492A1 (fr) 1992-10-06 1993-09-03 Utilisation de derives de 4-hydrazono-1,4-dihydro-pyridine et/ou 4-hydrazino-pyridine dans le traitement de l'hypertension et de l'insuffisance cardiaque congestive

Publications (1)

Publication Number Publication Date
AU5096893A true AU5096893A (en) 1994-04-26

Family

ID=25500544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50968/93A Abandoned AU5096893A (en) 1992-10-06 1993-09-03 Use of 4-hydrazono-1,4-dihydro-pyridine and/or 4-hydrazino-pyridine derivatives for treatment of hypertension and congestive heart failure

Country Status (2)

Country Link
AU (1) AU5096893A (fr)
WO (1) WO1994007492A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1031830B8 (fr) * 1999-02-23 2009-12-09 Asulab S.A. Système électrochimique pour la détermination d'un temps de coagulation du sang
PL353199A1 (en) 1999-08-30 2003-11-03 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
WO2001036351A2 (fr) 1999-11-19 2001-05-25 Corvas International, Inc. Antagonistes de l'inhibiteur des activateurs du plasminogène
US6638977B1 (en) 1999-11-19 2003-10-28 Corvas International, Inc. Plasminogen activator inhibitor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980379A (en) * 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse

Also Published As

Publication number Publication date
WO1994007492A1 (fr) 1994-04-14

Similar Documents

Publication Publication Date Title
AU2093392A (en) Treatment of congestive heart failure
AU3737397A (en) Minimally-invasive devices and methods for treatment of congestive heart failure
AU3074289A (en) 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
HUP9900773A3 (en) Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
AU3039995A (en) Heterocyclic derivatives of N-phenylamides
HUP9900947A3 (en) Process for the preparation of piperidine derivatives, intermediates and preparation thereof
AU4339896A (en) Treatment of hypertension and congestive heart failure
AU618231B3 (en) Treatment of emulsions
AU1115095A (en) Treatment of cellulose
AU694955B2 (en) Pyridazinone derivatives and processes for preparing the same
AU5184293A (en) Phthalazinone derivatives
AU1364092A (en) Amino-substituted pyrimidines, derivatives and methods of use therefor
AU3075595A (en) Anti-helicobacter heterocyclic derivatives of azolones
AU3730093A (en) Methods of treating diabetes
AU3695293A (en) Derivatives of adipogenesis inhibitory factor, their preparation and their use
AU5096893A (en) Use of 4-hydrazono-1,4-dihydro-pyridine and/or 4-hydrazino-pyridine derivatives for treatment of hypertension and congestive heart failure
AU5184393A (en) Substituted derivatives of diaminophthalimide
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU4954193A (en) Fullerene derivatives, method of synthesizing them and their use
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU6821196A (en) Transdermal administration of vorozole
AU2974097A (en) New derivatives of 10,11-dihydro-10-oxo-5h-dibenz/b,f/aze pine-5-carboxamide
AU1870295A (en) Novel derivatives of tetramethylcyclopropane
AU5635496A (en) Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid
AU1604692A (en) Treatment of longitudinally extending members